Implementing Regulation (EU) no. 2021/III of January 29, 2021 which has come into force on 30 January 2021 controls the export of Coronavirus vaccines by manufacturers that have concluded advance purchase agreements with the EU.

ADM has provided the first operational indications pending any further clarifications from the EU by directorial decision n. 34603 of 1 February 2021.

The video overview shows the procedure to be followed in order to be granted authorization for the export of coronavirus vaccines classified with the CN code 3002 20 10.